S. 2944Senate108th Congress (2003-2005)In Committee

A bill to provide that no funds may be expended by the United States Trade Representative to negotiate data exclusivity provisions for certain pharmaceutical products.

Sponsored by Ron WydenSen. Ron Wyden (D-OR)
Introduced October 8, 2004

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10848)

October 8, 2004

View full timeline
SenateIntro Referral

Introduced in Senate

October 8, 2004

SenateIntro Referral

Sponsor introductory remarks on measure. (CR S10847-10848)

October 8, 2004

SenateIntro Referral

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10848)

October 8, 2004

Floor Debate

13 members

What members said about S. 2944 on the floor

5 Republicans8 Democrats
Bob Graham
Sen. Bob GrahamD-FL · Oct 8, 2004

Mr. President, I rise today to introduce legislation that calls for a small Federal commitment that would make a huge impact on the daily lives of all Americans. This legislation, the Rush Hour…

Orrin G. Hatch
Sen. Orrin G. HatchR-UT · Oct 8, 2004

Mr. President, I rise today to introduce the Paiute Land Adjustments Act. This bill would authorize the Secretary of the Interior to convey or transfer four small Paiute trust land parcels totaling…

Jon S. Corzine
Sen. Jon S. CorzineD-NJ · Oct 8, 2004

Mr. President, I rise today, along with Senator Lautenberg, to introduce legislation to help ensure that convicted felons are not permitted to legally possess dangerous weapons. The bill would…

Daniel K. Akaka
Sen. Daniel K. AkakaD-HI · Oct 8, 2004

Mr. President, I rise to introduce the Taxpayer Abuse Prevention Act. Earned income tax credit (EITC) benefits intended for working families are increasingly being reduced by the growing use of…

Edward M. Kennedy
Sen. Edward M. KennedyD-MA · Oct 8, 2004

Mr. President, it is a privilege to join Senator Jack Reed in introducing the ``Emergency Flu Response Act of 2004.'' I commend him for his leadership on this important issue. I also commend our…

Show 8 more
Olympia J. Snowe
Sen. Olympia J. SnoweR-ME · Oct 8, 2004

Mr. President, I rise today to introduce bipartisan legislation, ``The Green Chemistry Research and Development Act,'' with Senator Rockefeller. Green chemistry is a science-based approach to…

Hillary Rodham Clinton
Sen. Hillary Rodham ClintonD-NY · Oct 8, 2004

Mr. President, I rise to introduce today a bill to authorize the development of the Coordinated Environmental Health Network. I am pleased to have Senators Chafee and Reid as cosponsors.…

Christopher S. Bond
Sen. Christopher S. BondR-MO · Oct 8, 2004

Mr. President, I rise today to introduce a bill of great importance to our most severely injured troops who are carrying the battle to the terrorists. This legislation will assist the Department of…

Patrick J. Leahy
Sen. Patrick J. LeahyD-VT · Oct 8, 2004

Mr. President, as in years past, I am offering today two pieces of legislation that would close a loophole in the 1996 Telecommunications Act, and as in years past I am pleased that I am joined by…

Jon Kyl
Sen. Jon KylR-AZ · Oct 8, 2004

Mr. President, I rise today to introduce legislation, the Ukraine Democracy and Fair Elections Act of 2004, designed to promote free, fair and transparent elections in Ukraine. Like the United…

Ron Wyden
Sen. Ron WydenD-OR · Oct 8, 2004

Mr. President, today I am introducing legislation regarding the way the trade policies of the United States affect the ability of developing countries to access to generic drugs. The bill addresses…

Ron Wyden
Sen. Ron WydenD-OR · Oct 8, 2004

Mr. President, today I am introducing legislation regarding the way the trade policies of the United States affect the ability of developing countries to access to generic drugs. The bill addresses…

Larry E. Craig
Sen. Larry E. CraigR-ID · Oct 8, 2004

Mr. President, I rise to introduce the Child Safety and Home Protection Act of 2004, to provide a limited tax credit for individuals who purchase a gun safe to store firearms in their homes. Under…

Show 1 more
Jack Reed
Sen. Jack ReedD-RI · Oct 8, 2004

I ask unanimous consent that the text of the bill be printed in the Record.

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued October 8, 2004
        [Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[S. 2944 Introduced in Senate (IS)]

108th CONGRESS
2d Session
S. 2944

To provide that no funds may be expended by the United States Trade
Representative to negotiate data exclusivity provisions for certain
pharmaceutical products.

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

October 8, 2004

Mr. Wyden introduced the following bill; which was read twice and
referred to the Committee on Finance

_______________________________________________________________________

A BILL

To provide that no funds may be expended by the United States Trade
Representative to negotiate data exclusivity provisions for certain
pharmaceutical products.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1. LIMITATION.

(a) In General.--Notwithstanding any other provision of law, funds
appropriated or otherwise obligated to the United States Trade
Representative may not be expended to negotiate data exclusivity
provisions with any country with respect to public health
pharmaceutical products or to require actions of another country which
interfere with a country's access to public health pharmaceutical
products.
(b) Definitions.--In this section:
(1) Data exclusivity provision.--The term ``data
exclusivity provision'' means a provision that restricts for a
set period of time a country from approving for sale generic
public health pharmaceutical products based on original
clinical data of public health pharmaceutical products
previously approved for sale.
(2) Public health pharmaceutical products.--The term
``public health pharmaceutical products'' means any patented
pharmaceutical product, or pharmaceutical product manufactured
through a patented process, needed to treat HIV/AIDS,
tuberculosis, malaria, or other epidemics, or needed in
circumstances of extreme urgency or national emergency in
accordance with the Decision of the General Council of 30
August 2003 on the Implementation of Paragraph Six of the DOHA
Declaration on the TRIPS Agreement and Public Health and the
WTO General Council Chairman's statement accompanying the
Decision (JOB(03)/177, WT/GC/M/82) (collectively known as the
``TRIPS/health solution'').
<all>